Intravenous belimumab plus SOC vs placebo plus SOC was not linked to an increased risk for infection among patients with SLE.

In light of recent federal research funding cuts, the Arthritis Foundation and CARRA each contributed an additional $100,000 to support the grant program this year. Meanwhile, demand for research ...

Cullinan's innovative approach and Zipalertinib's potential approval in 2026 position it as a promising biotech investment.

At cloud-based human capital management company Dayforce, adding WellTheory's specialized support to their benefits in ...

The diagnosis of several of them can be aided by blood tests and/or imaging. There may not be a cure, but with lifestyle ...

You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...

Viewing lupus decision aids without interruption leads to better patient-reported outcomes, regardless of whether they are ...

Lumos Diagnostics shares today soared by more than 150pc after the company unveiled a US distribution deal worth as much as ...

Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended June 30, 2025, before the market opens on Tuesday, July 29, 2025.

Senior medical experts have explained why women are more at risk of developing arthritis than men, attributing it to several ...

People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...

Last week Tuesday, PureTech had announced that Raju Kucherlapati stepped down immediately as chair and was replaced by Sharon Barber-Lui, who will be interim chair and also lead the process for ...